Clinical Trials

Our mission is to improve the cure rate of patients with PTCL and reduce treatment-related toxicity by developing novel targeted therapy using rationally designed small molecules, antibodies and combination regimens of biologic agents. For referrals, please contact ayounes@mdanderson.org or Amanda Copeland at ARCopeland@mdanderson.org.

Casey Carleton, a patient with metastatic melanoma explains his experience and success on Phase 1 clinical trial. Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center. http://bit.ly/khHJA7

How does a doctor determine whether a drug will work if he doesn’t know what other drugs the patient is taking? This perplexing question challenged Dominion Diagnostics, a laboratory specializing in urine drug testing and medication monitoring. Without knowing exactly what the medications are, the number of possible drug interactions is mind numbing. Questioning the patient is no guarantee of accuracy. View the video to find out how Dominion Diagnostics met this challenge.

Fox Morning News welcomes Pediatrician Doctor Bob Sears to discuss natural remedies. Renowned pediatrician Dr. Bob Sears has had excellent results with his patients using Bionorica's Sinupret for Kids.

J. Kocsis, PhD. - The current approaches to the therapy of multiple sclerosis are reviewed by J. Kocsis (Yale University). His research emphasizes remyelination as an approach to the therapy of multiple sclerosis and spinal cord injury.

Z. Khachaturian, PhD. - New approaches to the therapy of Alzheimer’s disease (AD) are discussed in video interviews of this series. According to Z. Khachaturian (Potomac, MD) substantial progress has been made during the last 10 years in our understanding of pathogenesis of Alzheimer’s disease as well as in the discovery of biomarkers and therapeutic approaches. In addition to cholinergic drugs, inhibitors of plaque formation have been discovered, but the currently available...